Millstone Evans Group’s Mural Oncology MURA Stock Holding History

Millstone Evans Group’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,730	Closed	-$3.58K	–	867
2025 Q3	$3.58K	Hold	1,730	–	–	﹤0.01%	672
2025 Q2	$4.27K	Hold	1,730	–	–	﹤0.01%	601
2025 Q1	$2.18K	Hold	1,730	–	–	﹤0.01%	691
2024 Q4	$5.57K	Buy	+1,730	New	+$6.1K	﹤0.01%	556

Millstone Evans Group's MURA Position: Q4 2025 in Review

Millstone Evans Group sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 1,730 shares — an estimated $3.58K sold.

Millstone Evans Group first reported a position in MURA in Q4 2024 and held it in 4 quarters. The position peaked at $5.57K in Q4 2024. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

Millstone Evans Group reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
Millstone Evans Group sold 1,730 Mural Oncology shares in Q4 2025, an estimated $3.58K.
Millstone Evans Group first reported a position in Mural Oncology in Q4 2024 and held it in 4 quarters.
Millstone Evans Group's Mural Oncology position peaked at $5.57K in Q4 2024.
0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on Millstone Evans Group's 13F filing for Q4 2025, filed 2 Feb 2026.